Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,053 | 10,460 | 11,941 | 14,399 | 13,319 |
| Receivables | 147 | 125 | 164 | 138 | 162 |
| Inventories | 3,622 | 3,548 | 5,428 | 5,498 | 5,476 |
| Other current assets | 905 | 978 | 1,704 | 1,669 | 3,233 |
| TOTAL | $12,727 | $15,111 | $19,237 | $21,704 | $22,190 |
| Non-Current Assets | |||||
| PPE Net | 9,161 | 9,419 | 10,520 | 10,589 | 10,704 |
| Investments And Advances | 0 | 0 | 11 | 11 | 11 |
| Intangibles | 937 | 917 | 426 | 411 | 405 |
| Other Non-Current Assets | 1,341 | 1,387 | 1,094 | 1,121 | 1,134 |
| TOTAL | $11,439 | $11,723 | $12,051 | $12,132 | $12,254 |
| Total Assets | $24,166 | $26,834 | $31,288 | $33,836 | $34,444 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3 | N/A | 3 | 3 | 3 |
| Accounts payable and accrued liabilities | 456 | 981 | 357 | 418 | 567 |
| Accrued Expenses | 1,200 | 1,460 | 919 | 1,594 | 1,542 |
| TOTAL | $1,659 | $2,441 | $1,279 | $2,015 | $2,112 |
| Non-Current Liabilities | |||||
| Long Term Debt | 143 | 144 | 145 | 146 | 147 |
| Other Non-Current Liabilities | 324 | 357 | 389 | 419 | 448 |
| TOTAL | $467 | $501 | $534 | $565 | $595 |
| Total Liabilities | $2,126 | $2,942 | $1,813 | $2,580 | $2,707 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,534 | 51,744 | 51,054 | 51,051 | 49,784 |
| Common Shares | 117,171 | 116,019 | 114,894 | 114,371 | 110,528 |
| Retained earnings | -91,944 | -89,159 | -82,656 | -80,275 | -75,931 |
| Other shareholders' equity | -3,187 | -2,968 | -2,763 | -2,840 | -2,860 |
| TOTAL | $22,040 | $23,892 | $29,475 | $31,256 | $31,737 |
| Total Liabilities And Equity | $24,166 | $26,834 | $31,288 | $33,836 | $34,444 |